INSIGHTS ON DRUG DEVELOPMENT
-
Aggregate Analysis Of Semaglutide
Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.
-
Why CDMO Performance Drops Exactly When It Matters Most
Programs often stall moving to GMP due to fragmented workflows and knowledge gaps. Aligning teams and integrating development with execution, via continuous data, sustains momentum and reduces risk.
-
Faster Clones, Simpler Process: What's Changing In CHO Expression?
This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.
-
Target Product Profile (TPP) Explained
Learn how to best align your development strategy, guide cross-functional decisions, and build a clear pathway from discovery to successful commercialization.
-
Safety First: Considerations When Formulating High Potency Compounds9/23/2026
Developing highly potent APIs comes with unique challenges. Explore strategies for managing risk, protecting personnel, and advancing programs with confidence.
-
A Fast And Simple ddPCR Assay For In-Depth AAV Characterization4/1/2026
Achieve precise AAV characterization with a streamlined digital assay. This video illustrates a rapid, four-step workflow that delivers accurate empty-to-full ratios in under eight hours.
-
Overcoming Gene Therapy Cost Roadblocks On The Path To Patients7/23/2025
Viral vector-based gene therapies are expanding beyond rare diseases to treat larger populations. Discover how innovations in manufacturing are making these life-changing treatments more accessible.
-
High-Dose Delivery: Integration And Performance8/12/2026
High-viscosity therapies bring new delivery challenges. Explore how needle, syringe, and device design affect injection performance, reliability, and user experience.
-
EMA Support For SMEs Through Scientific Advice And Early Dialogue5/6/2026
Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and de‑risk innovative programs through early dialogue.
DRUG DEVELOPMENT SOLUTIONS
-
Powerful tools for characterizing protein-protein interactions, structural stability, and formulation compatibility.
-
Multicolor Multiphoton gets you closer to the truth
The combination of multiple distinct fluorescent labels is increasingly used to study dynamic interaction and spatial relationships among cells and molecules. The goal is to understand a myriad of complex biological events, such as cellular connectivity, cell phenotyping, protein interaction or co-expression, and co-localization. Scaling up such studies to whole organs or tissues requires suitable large-volume multicolor microscopy methods. DIVE and STELLARIS have now merged to provide you with the power of flexible multicolor multiphoton imaging. Furthermore, you can expand the potential of your experiments with additional label-free imaging capabilities.
Seamlessly integrated into the confocal software interface, STELLARIS 8 DIVE multiphoton microscope offers the benefits of high speed and excellent navigation so that dynamic processes in complex samples can be studied with ease. STELLARIS 8 DIVE – A rainbow of possibilities for your research.
-
The LevMixer™ 10 L single-use mixing system is a low volume mixer designed for both upstream and downstream applications.
-
Access the future of AI microscopy
Subjectivity of analysis and poor reproducibility are key hurdles to be overcome for biological image analysis. Standard segmentation can lead to sub-standard results and require substantial manual curation which is subject to human error.
-
Explore chromatography methods for sample preparation, residual solvent, and impurity analysis, critical steps for Active Pharmaceutical Ingredient (API) quality control.